Forest Laboratories Inc. and Cypress Bioscience Inc. said Tuesday a late-stage study on the depression drug Milnacipran as fibromylagia treatment met its primary goals.
From: biz.yahoo.com
Forest Posts Positive Fibromylagia Data
Posted by Ruslan Abuzant at 5:19 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment